History & Overview
Annual Report
President's Pages
Center News
Community Affairs
Make a Gift
Cycle for Survival
Fred's Team
Rock & Run on the River
Yankees Universe Fund
Thomas Blake Sr. Memorial Research Fund
Donating Blood & Platelets
Volunteering
Thrift Shop
Park Avenue Potluck CELEBRATIONS
Press Releases
In the News
Information for Journalists
News@MSKCC
Manhattan
New Jersey
Long Island
Westchester
Working at Memorial Sloan-Kettering
Work Sites
College Recruitment
About Nursing
Job Fairs & Career Days
IS Careers
Job Search & Apply Online
Clinical Research Program
Brain Tumor & Central Nervous System
Breast Cancer
Colorectal Cancer
Genitourinary Cancer
Gynecologic Cancer
Clinical Trials
Disease Management Team
Head and Neck Cancer
Hematology
Hepatobiliary
Infectious Disease
Integrative Medicine
Leukemia
Lymphoma
Melanoma
Pain Management
Pediatric Cancers
Primary Bone
Psychiatry and Behavioral Sciences
Radiation Sciences
Soft Tissue Sarcoma
Thoracic
Transplantation
Upper Gastrointestinal
Home
>
Research
>
Memorial Hospital Research
>
Clinical Research Program
>
Gynecologic Cancer
Clinical Trials
Clicking a link below will scroll the
page down to the relevant section
Cervical Cancer
Endometrial and other Uterine Cancers
Leiomyosarcoma
Ovarian Cancer
Vulvar Cancer
Top
Cervical Cancer
A Phase III Trial of Cisplatin plus Paclitaxel with and without Bevacizumab versus Topotecan plus Paclitaxel, with and without Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
Leitao, Mario, MD
[Protocol 09-098]
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
Chi, Dennis, MD
[Protocol 05-001]
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
Chi, Dennis, MD
[Protocol 08-155]
Endometrial and other Uterine Cancers
A Phase I/II Study of the Tor Kinase Inhibitor AZD8055 in Patients with Advanced Solid Tumors, Lymphomas, or Endometrial Carcinoma
Aghajanian, Carol, MD
[Protocol 08-093]
A Phase II Trial of Temsirolimus or the Combination of Hormonal Therapy Plus Temsirolimus in Women with Advanced, Persistent, or Recurrent Endometrial Carcinoma
Aghajanian, Carol, MD
[Protocol 09-019]
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
Chi, Dennis, MD
[Protocol 05-001]
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
Chi, Dennis, MD
[Protocol 08-155]
Estrogen, Diet, Genetics & Endometrial Cancer
Olson, Sara, PhD
[Protocol 01-119]
Leiomyosarcoma
A Phase II Trial of Sorafenib and Dacarbazine in Soft-Tissue Sarcoma
D'Adamo, David, MD
[Protocol 08-068]
A Randomized Phase II Trial of Gemcitabine and Docetaxel with or without Bevacizumab in Leiomyosarcoma, Malignant Fibrous Histiocytoma, and Angiosarcoma
D'Adamo, David, MD
[Protocol 09-015]
Ovarian Cancer
A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer
Chi, Dennis, MD
[Protocol 01-048]
A Phase I Study of AGS-8M4 Given as Monotherapy in Patients with Advanced Ovarian Cancer
Sabbatini, Paul, MD
[Protocol 08-111]
A Phase I Study of NY-ESO-1 Overlapping Peptides with or without Montanide Vaccination in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Second or Third Remission
Sabbatini, Paul, MD
[Protocol 07-152]
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
Aghajanian, Carol, MD
[Protocol 06-155]
A Phase I/II Study of BMS-753493 in Patients with Advanced Cancer
Konner, Jason, MD
[Protocol 08-032]
A Phase IB Study Evaluating the Safety of BSI-201 in Combination with Chemotherapeutic Regimens in Patients with Advanced Solid Tumors
Bell-McGuinn, Katherine, MD, PhD
[Protocol 08-048]
A Phase II Study of AZD6244 in Women with Recurrent Low-Grade Serous Ovarian Cancer
Leitao, Mario, MD
[Protocol 09-007]
A Phase II Study of Bevacizumab for Recurrent Malignant Stromal Tumors of the Ovary
Leitao, Mario, MD
[Protocol 09-062]
A Phase II Study of Carboplatin and Gemcitabine with or without Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Aghajanian, Carol, MD
[Protocol 07-078]
A Phase II Study of GDC-0449 as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
Sabbatini, Paul, MD
[Protocol 09-059]
A Phase II Study of the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer
Kauff, Noah, MD
[Protocol 08-150]
A Phase III Study of Carboplatin and Paclitaxel Alone or with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Leitao, Mario, MD
[Protocol 08-074]
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
Chi, Dennis, MD
[Protocol 05-001]
A Randomized Study of MORAb-003 (Farletuzumab) Plus Paclitaxel in Patients with Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Konner, Jason, MD
[Protocol 08-149]
Decision Making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Testing for Inherited BRCA1 and BRCA2 Mutations
Hurley, Karen, PhD
[Protocol 03-001]
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
Chi, Dennis, MD
[Protocol 08-155]
Vulvar Cancer
A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease
Chi, Dennis, MD
[Protocol 07-029]
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
Chi, Dennis, MD
[Protocol 05-001]
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
Chi, Dennis, MD
[Protocol 08-155]
Site Map
|
Index
Legal Disclaimer
|
Privacy Practices
|
Public Notices
©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000
1275 York Avenue New York, NY 10065.
PublicAffairs@mskcc.org